Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FLEXION THERAPEUTICS, INC.

(FLXN)
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Sliding in Late Monday Trading

10/11/2021 | 03:52pm EST


ę MT Newswires 2021
All news about FLEXION THERAPEUTICS, INC.
11/22NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
11/19Northland Securities Downgrades Flexion Therapeutics to Market Perform From Outperform,..
MT
11/19FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Termination of a Ma..
AQ
11/19FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P TMI Index
CI
11/19FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P Global BMI Index
CI
11/19FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Composite Index
CI
11/18FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Biotechnology Index
CI
11/12FLEXION THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
11/12Flexion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
10/30SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Flexion Thera..
PR
More news
Analyst Recommendations on FLEXION THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -65,0 M - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 459 M 459 M -
Capi. / Sales 2021 -
EV / Sales 2022
Nbr of Employees -
Free-Float 95,6%
Chart FLEXION THERAPEUTICS, INC.
Duration : Period :
Flexion Therapeutics, Inc. Technical Analysis Chart | FLXN | US33938J1060 | MarketScreener
Technical analysis trends FLEXION THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Michael D. Clayman President, Chief Executive Officer & Director
Frederick W. Driscoll Chief Financial Officer
Patrick J. Mahaffy Chairman
William T. Andrews Chief Medical Officer
Carolyn Beaty Scimemi Chief Compliance Officer & Head-Legal Affairs
Sector and Competitors
1st jan.Capi. (M$)
FLEXION THERAPEUTICS, INC.-20.97%459
GILEAD SCIENCES, INC.18.31%86 465
BIONTECH SE331.48%84 953
WUXI APPTEC CO., LTD.28.27%66 734
REGENERON PHARMACEUTICALS31.76%66 553
VERTEX PHARMACEUTICALS-20.90%47 530